Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "User talk:Laner Verena/My sandbox"

From Bioblast
Line 6: Line 6:
<div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;">
<div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;">


* ''Breaking news:'' '''[[MITOEAGLE]]''' - a new COST Action approved: ''The large number of proposers spread across many EU countries and employed in a range of sectors is an early indication of the relevance and timeliness of this study'' (2016 Feb).
* OROBOROS INSTRUMENTS gets HORIZON 2020 funding for two Marie Skłodowska-Curie-Projects:
 
:: '''TRACT''' – '''Tra'''ining in '''C'''ancer mechanisms and '''T'''herapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. '''''[[TRACT|More info? - Apply now!]]'''''
 
::'''TRANSMIT'''- Start in January 2017.
 
 


* '''[[MitoFit news]]'''


</div>
</div>

Revision as of 14:58, 16 October 2016

  • OROBOROS INSTRUMENTS gets HORIZON 2020 funding for two Marie Skłodowska-Curie-Projects:
TRACTTraining in Cancer mechanisms and Therapeutics: TRACT will enable eleven PhD Fellows to complete research projects in the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms. This will allow for the discovery of novel insights into the molecular and cellular basis of oral and oesophageal cancer and generate new diagnostic tools and therapeutics that will improve patient response and survival. More info? - Apply now!
TRANSMIT- Start in January 2017.